We serve Chemical Name:S-(2-acetamidoethyl) ethanethioate CAS:1420-88-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:S-(2-acetamidoethyl) ethanethioate
CAS.NO:1420-88-8
Synonyms:S-acetyl-N-acetylcysteamine;1-acetylamino-2-acetylsulfanyl-ethane;N,S-diacetylcysteamine;EINECS 215-821-1;1-Acetylamino-2-acetylmercapto-aethan;Thioacetic acid S-2-acetamidoethyl ester;N,S-Diacetyl-2-mercaptoethylamine
Molecular Formula:C6H11NO2S
Molecular Weight:161.22200
HS Code:2930909090
Physical and Chemical Properties:
Melting point:29-31ºC(lit.)
Boiling point:181-182ºC15 mm Hg(lit.)，316.1ºC at 760 mmHg
Density:1.114 g/cm3
Index of Refraction:1.485
PSA:71.47000
Exact Mass:161.05100
LogP:0.79310
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like S-acetyl-N-acetylcysteamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N,S-Diacetyl-2-mercaptoethylamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Thioacetic acid S-2-acetamidoethyl ester Use and application,S-acetyl-N-acetylcysteamine technical grade,usp/ep/jp grade.
Related News: Contract research organisation Charles River Laboratories International Inc. today announced plans for an €8M expansion of its testing capabilities at its Ballina, Co. Mayo site that will give an additional 1,500m2 of lab space and create up to 90 new skilled roles over the next three years. (S)-3-((S)-2-Amino-4-methyl-pentanoylamino)-N-((S)-carbamoyl-phenyl-methyl)-succinamic acid tert-butyl ester manufacturers The expansion will include six 1,000L small molecule reactors, four 1,500L vessels, and isolation equipment providing mid-scale capacity to bridge between early-phase and late-phase production. 2,2-Bis-(4-carboxy-anilino)-1-(1)naphthyl-ethanon suppliers Conducted by Innovent in China, the CIBI321A101 trial is a Phase 1a open-label, multi-center study of the safety, tolerability and primary efficacy of IBI321 in patients with advanced solid tumors. Phase 1a of the study will evaluate dosing of IBI321 in a variety of solid tumors (ClinicalTrials.gov, NCT04911894). 1-Acetoxymethyl-1-ethyl-2,3,4,6,7,12-hexahydro-1H-indolo[2,3-a]quinolizin-5-ylium; perchlorate vendor & factory.
